Lantern Pharma gains FDA IND clearance for LP-284 to treat non-Hodgkin's lymphoma

Accuray launches global training center at Madison HQ for advanced radiotherapy education

Cantargia AB secures USD1.1m US grant for nadunolimab leukaemia clinical trial

RedHill receives FDA sNDA approval for Talicia with improved dosing regimen

Samsung Biologics signs new contract with Bristol Myers Squibb

Phanes Therapeutics adds Professor Shun Lu to Clinical Advisory Board

Charles River and Related Sciences collaborate to use Logica for AI-enabled drug discovery

Synaffix BV signs licensing agreement with ABL Bio

NanoString Technologies introduces GeoMx IO Proteome Atlas (IPA) For spatial proteomics

TME Pharma N.V. reports 17-month survival success with NOX-A12 and bevacizumab combination for glioblastoma

Dewpoint Therapeutics collaborates with Chemify

Pierre Fabre Laboratories acquires Vertical Bio AG

Beactica Therapeutics adds new members to preclinical development team

MaaT Pharma and Skyepharma complete Europe's largest microbiome manufacturing facility

IDEAYA Biosciences commences phase one monotherapy expansion in IDE161 trial